Literature DB >> 31879513

A Bridge Still Too Far.

Tzung-Dau Wang1, Kang-Ling Wang2,3, Chern-En Chiang2,3.   

Abstract

Year:  2019        PMID： 31879513      PMCID： PMC6859108          DOI： 10.6515/ACS.201911_35(6).20191028A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  17 in total

1.  Predictors of Mortality in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Cheng-Chun Wei; Shih-Huang Lee
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

2.  Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.

Authors:  Jeong Euy Park; Chern-En Chiang; Muhammad Munawar; Gia Khai Pham; Apichard Sukonthasarn; Anastacio R Aquino; Kah Lin Khoo; Hon Wah Raymond Chan
Journal:  Eur J Prev Cardiol       Date:  2011-03-07       Impact factor: 7.804

3.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

Review 4.  Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients.

Authors:  Yi-Heng Li; Ting-Hsing Chao; Ping-Yen Liu; Kwo-Chang Ueng; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

5.  Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.

Authors:  Robert P Giugliano; Terje R Pedersen; Jeong-Gun Park; Gaetano M De Ferrari; Zbigniew A Gaciong; Richard Ceska; Kalman Toth; Ioanna Gouni-Berthold; Jose Lopez-Miranda; François Schiele; François Mach; Brian R Ott; Estella Kanevsky; Armando Lira Pineda; Ransi Somaratne; Scott M Wasserman; Anthony C Keech; Peter S Sever; Marc S Sabatine
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

Review 6.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Authors:  Michael G Silverman; Brian A Ference; Kyungah Im; Stephen D Wiviott; Robert P Giugliano; Scott M Grundy; Eugene Braunwald; Marc S Sabatine
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

7.  The association between low-density lipoprotein cholesterol goal attainment, physician and patient attitudes and perceptions, and healthcare policy.

Authors:  Kang-Ling Wang; Cheng-Hsueh Wu; Ko-Fan Wang; Chun-Chin Chang; Lung-Ching Chen; Tse-Min Lu; Shing-Jong Lin; Chern-En Chiang
Journal:  J Atheroscler Thromb       Date:  2014-06-02       Impact factor: 4.928

8.  Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

Authors:  David D Waters; Carlos Brotons; Cheng-Wen Chiang; Jean Ferrières; JoAnne Foody; J Wouter Jukema; Raul D Santos; Juan Verdejo; Michael Messig; Ruth McPherson; Ki-Bae Seung; Lisa Tarasenko
Journal:  Circulation       Date:  2009-06-22       Impact factor: 29.690

9.  Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan.

Authors:  Jiann-Shing Jeng; Wei-Hsian Yin; Chin-Chou Huang; Shao-Yuan Chuang; Hung-I Yeh; Ching-Chang Fang; Tsung-Hsien Lin; Kuo-Yang Wang; Wei-Kung Tseng; Lien-Chi Huang; Kwo-Chang Ueng; I-Chang Hsieh; Yi-Heng Li; Wen-Harn Pan; Chau-Chung Wu; Jaw-Wen Chen
Journal:  J Formos Med Assoc       Date:  2013-11-22       Impact factor: 3.282

10.  Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Authors:  Gregory G Schwartz; P Gabriel Steg; Michael Szarek; Deepak L Bhatt; Vera A Bittner; Rafael Diaz; Jay M Edelberg; Shaun G Goodman; Corinne Hanotin; Robert A Harrington; J Wouter Jukema; Guillaume Lecorps; Kenneth W Mahaffey; Angèle Moryusef; Robert Pordy; Kirby Quintero; Matthew T Roe; William J Sasiela; Jean-François Tamby; Pierluigi Tricoci; Harvey D White; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2018-11-07       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.